Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study.

This study demonstrates that the chronic use of the novel MCO dialyser Theranova® appears to be safe and well-tolerated, without serious side effects or hypoalbuminaemia, as well as fewer infections. These results need to be confirmed in larger randomized clinical trials.